HQ2304

The main purpose of the study is to compare the pharmacokinetics of HQ2304 capsules (specifications: 10mg/1100mg, 20mg/1100mg) and the control drug Rabeprazole Sodium Enteric-coated Tablets (trade name: Polite®, specifications: 10mg, 20mg) in healthy Chinese subjects after a single dose in the fasting state; to provide a reference for the design of subsequent trials. The secondary purpose of the study is to evaluate the safety and tolerability of HQ2304 capsules and the control drug Rabeprazole Sodium Enteric-coated Tablets in healthy Chinese subjects.